BioLine RX Ltd ADR buy melinda
Start price
27.01.17
/
50%
€217.16
Target price
16.02.17
€253.69
Performance (%)
20.49%
End price
16.02.17
€261.64
Summary
This prediction ended on 16.02.17 with a price of €261.64. The prediction had a final performance of 20.49%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| BioLine RX Ltd ADR | -8.065% | -8.065% | -45.192% | -77.200% |
| iShares Core DAX® | 2.594% | -1.158% | 14.782% | 16.813% |
| iShares Nasdaq 100 | 3.553% | -1.727% | 43.265% | 44.227% |
| iShares Nikkei 225® | 0.687% | -8.354% | 18.454% | 1.361% |
| iShares S&P 500 | 2.209% | -0.942% | 31.361% | 42.812% |
According to melinda what are the pros and cons of BioLine RX Ltd ADR for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread BioLine RX Ltd ADR diskutieren
folgen
Phase 2 - Studie März eingeleitet 2016. Teildaten aufgrund 1Q 2017 erste Ergebnisse bis Ende 2017
Stopped prediction by melinda for BioLine RX Ltd ADR
BioLine RX Ltd ADR
Start price
Target price
Perf. (%)
€2.46
03.11.20
03.11.20
€3.50
04.11.21
04.11.21
-4.88%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
BioLine RX Ltd ADR
Start price
Target price
Perf. (%)
€148.15
03.11.18
03.11.18
€284.13
22.01.19
22.01.19
-20.14%
22.01.19
22.01.19
Could be worthwhile Investment >10% per year
BioLine RX Ltd ADR
Start price
Target price
Perf. (%)
€219.19
18.11.17
18.11.17
€304.43
18.05.18
18.05.18
-14.59%
18.05.18
18.05.18
Could be worthwhile Investment >10% per year
BioLine RX Ltd ADR
Start price
Target price
Perf. (%)
€166.40
28.06.16
28.06.16
€192.80
24.08.16
24.08.16
21.91%
24.08.16
24.08.16
Could be worthwhile Investment >10% per year